Subscribe to RSS
DOI: 10.1055/s-2006-924999
Safety and Efficacy of Endoscopic Balloon Dilation for Treatment of Crohn’s Disease Strictures
Publication History
Submitted 25 November 2004
Accepted after revision 5 July 2005
Publication Date:
09 May 2006 (online)
Background and Study Aims: Strictures are a substantial cause of morbidity in patients with Crohn’s disease. Endoscopic balloon dilation is a therapeutic option in limited strictures to avoid intestinal surgery, although there have been few reports regarding the long-term outcome.
Patients and Methods: Balloon dilation was scheduled for 46 patients (26 women, 20 men; median age 34) with Crohn’s-associated symptomatic and radiographically confirmed intestinal stenosis. The study plan envisaged up to four consecutive treatments within the first 2 months until relief of symptoms, and thereafter dilations depending on clinical requirements.
Results: Dilation was not possible in seven of the 46 patients (15 %), due to technical problems (n = 2), internal fistulas (n = 3), or absence of a stenosis (n = 2). Thirty-nine patients received at least one treatment. The site of obstruction was the ileocolonic anastomosis in 23 of the 39 patients (59 %) and surgically untreated areas in 16 patients (41 %). After the initial dilation series (median 1, interquartile range 1-2), strictures were traversed in 37 of the 39 patients (95 %). During a median follow-up period of 21 months (range 3-98 months), 24 of the 39 patients (62 %) underwent a repeat intervention, including 12 (31 %) with repeat dilation, 11 (28 %) with surgical resection, and one patient who received an intestinal stent. The cumulative percentages of patients without a repeat intervention or surgery at 6, 12, 24, and 36 months were 68 %, 48 %, 36 %, and 31 %, and 97 %, 91 %, 84 % and 75 %, respectively. Two perforations and one case of severe bleeding were seen in the 73 dilation procedures (4 %) performed.
Conclusions: Endoscopic balloon dilation is a safe and effective method that allows surgery to be avoided in approximately 75 % of patients with Crohn’s-associated short intestinal strictures. However, recurrent symptoms frequently make it necessary to repeat the procedure.
References
- 1 Cosnes J, Cattan S, Blain A. et al . Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002; 8 244-250
- 2 Louis E, Collard A, Oger A F. et al . Behavior of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001; 49 777-782
- 3 Gasche C, Scholmerich J, Brynskov J. et al . A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000; 6 8-15
- 4 Oberhuber G, Stangl P C, Vogelsang H. et al . Significant association of strictures and internal fistula formation in Crohn’s disease. Virchows Arch. 2000; 437 293-297
- 5 Rutgeerts P, Geboes K, Vantrappen G. et al . Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984; 25 665-672
- 6 Stebbing J F, Jewell D P, Kettlewell M G. et al . Recurrence and reoperation after strictureplasty for obstructive Crohn’s disease: long term results. Br J Surg. 1995; 82 1471-1474
- 7 Dietz D W, Laureti S, Strong S A. et al . Safety and long-term efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg. 2001; 192 330-337
- 8 Sabate J M, Villarejo J, Bouhnik Y. et al . Hydrostatic balloon dilatation of Crohn’s strictures. Aliment Pharmacol Ther. 2003; 18 409-413
- 9 Thomas-Gibson S, Brooker J C, Hayward C M. et al . Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol. 2003; 15 485-488
- 10 Dear K L, Hunter J O. Colonoscopic hydrostatic balloon dilatation of Crohn’s strictures. J Clin Gastroenterol. 2001; 33 315-318
- 11 Brooker J C, Beckett C G, Saunders B P. et al . Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome: a retrospective case series. Endoscopy. 2003; 35 333-337
- 12 Greenstein A J, Lachman P, Sachar D B. et al . Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut. 1988; 29 588-592
- 13 Borley N R, Mortensen N J, Chaudry M A. et al . Recurrence after abdominal surgery for Crohn’s disease: relationship to disease site and surgical procedure. Dis Colon Rectum. 2002; 45 377-383
- 14 Couckuyt H, Gevers A M, Coremans G. et al . Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective long-term analysis. Gut. 1995; 36 577-580
- 15 Ramboer C, Verhamme M, Dhondt E. et al . Endoscopic treatment of stenosis in recurrent Crohn’s disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc. 1995; 42 252-255
- 16 Lavy A. Triamcinolone improves outcome in Crohn’s disease strictures. Dis Colon Rectum. 1997; 40 184-186
- 17 Matsuhashi N, Nakajima A, Suzuki A. et al . Long-term outcome of non-surgical strictureplasty using metallic stents for intestinal strictures in Crohn’s disease. Gastrointest Endosc. 2000; 51 343-345
- 18 Blomberg B, Rolny P, Jarnerot G. Endoscopic treatment of anastomotic strictures in Crohn’s disease. Endoscopy. 1991; 23 195-198
A. Püspök, M.D.
Division of Gastroenterology and Hepatology
Department of Internal Medicine IV · Medical University of Vienna · Währinger Gürtel 18-20 · 1090 Vienna · Austria
Fax: +43-1-40400-4735·
Email: andreas.puespoek@meduniwien.ac.at